Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Insurance Status Linked to Cancer Stage at Diagnosis
Link ID 3495
Title Insurance Status Linked to Cancer Stage at Diagnosis
Url http://www.medscape.com/viewarticle/570524?src=rss
Description Uninsured patients and those covered by Medicaid are far more likely to present with advanced-stage cancer at diagnosis than those with private coverage. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Feb 23, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Consolidation Radioimmunotherapy Safe and Effective in Patients With Follicular NHL
  Consolidation treatment with radioactive yttrium-90 ibritumomab tiuxetan is feasible, well tolerated, and effective in untreated patients with follicular non-Hodgkin lymphoma. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. New Agents in Thyroid Cancer Trials Suggest Treatment Paradigm Shift is "Not Far Off"
  Several new agents are showing activity in refractory thyroid cancer, suggesting that a treatment paradigm shift is "not far off." Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Toremifene Reduces Fractures and Hot Flashes From ADT in Prostate Cancer
  Toremifene reduces hot flashes and vertebral fractures in men with prostate cancer on androgen-deprivation therapy for prostate cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Neuroblastoma Linked to Genetic Variants on Chromosome 6
  Children with this genetic variant, identified for the first time in a genome-wide association study, develop a particularly aggressive form of neuroblastoma. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Zoledronic Acid-Thalidomide Combination Does Not Increase Renal Risk
  Maintenance therapy with zoledronic acid and thalidomide in patients with multiple myeloma does not increase the risk of renal impairment, according to a report posted on March 31st by BMC Clinical Pharmacology. Reuters Health Information
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS